Keywords
COVID-19 vaccines, genetic predisposition to disease, purpura, thrombocytopenic, idiopathic, thrombocytopenia
Abstract
Background: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare life-threatening thrombotic reaction to COVID-19 vaccines.
Case description: Two young male first cousins, with a family history of idiopathic thrombocytopenic purpura, developed VITT after the Ad26.COV2.S vaccine. Both had a favourable clinical and analytical outcome. We investigated the genetic factors that could be associated with a genetic predisposition to VITT.
Conclusions: There are no published cases where the VITT patients were relatives. The genetic study did not reveal any likely pathogenic variants, although the prevalent polymorphism c.497A>G (p.(His166Arg)) in the FCGR2A gene was found in a homozygous state. More studies are required to better understand VITT’s pathophysiology and any underlying genetic predispositions.
References
![](https://www.ejcrim.com/public/journals/1/submission_4546_4081_coverImage_en_US.jpg)
Views: 437
HTML downloads: 24
PDF downloads: 201
Published:
2024-05-14
Issue:
2024: Vol 11 No 6
(view)